AstraZeneca Q3 2026 Earnings - Core EPS: $2.79 (Est $2.62) - Revenue: $16.21B (Est $15.98B) - Core Operating Margin: 36% (Est 33.6%) - Reaffirms Core Revenue and EPS Guidance.
AstraZeneca Q3 2026 Earnings - Core EPS: $2.79 (Est $2.62) - Revenue: $16.21B (Est $15.98B) - Core Operating Margin: 36% (Est 33.6%) - Reaffirms Core Revenue and EPS Guidance.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in